4

OWNERSHIP DOCUMENT

Company: Matinas BioPharma Holdings, Inc.
Filed: October 3, 2018
Period of Report: October 1, 2018
Accession Number: 0000905718-18-000821

View Document ↗ View on SEC.gov ↗